In Depth
Also in this section
Subcutaneous drugs grant a new lease on life to checkpoint inhibitors
Hope for the UK clinical trial landscape but it requires a lot of work
Novo Nordisk’s Wegovy to start being supplied by NHS in England
Minimal impact expected for first ten drugs released for Medicare price negotiation
Q&A: Human touch remains critical for the patient experience in trials